Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Pathology|February 20, 2013
Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastasesCanan Akfirat, Xiaotun Zhang, Aviva Ventura, et al.
Nature Communications|March 4, 2021
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingLauren Brady, Michelle Kriner, Ilsa Coleman, et al.
Endocrinology|January 3, 2020
Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate CancerSulgi Park, Chung-Seog Song, Chun-Lin Lin, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
British Journal of Cancer|September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bonesPaulina Nastały, Sara Stoupiec, Marta Popęda, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Cancer|February 14, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillanceJonathan L Wright, Jeannette M Schenk, Roman Gulati, et al.
Plos One|August 13, 2013
Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxiaHeather H Cheng, Patrick S Mitchell, Evan M Kroh, et al.
The Journal of Clinical Investigation|November 25, 2010
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progressionAnkur Sharma, Wen-Shuz Yeow, Adam Ertel, et al.
Oncotarget|October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathwaysLisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Pathology|February 20, 2013
Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastasesCanan Akfirat, Xiaotun Zhang, Aviva Ventura, et al.
Nature Communications|March 4, 2021
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingLauren Brady, Michelle Kriner, Ilsa Coleman, et al.
Endocrinology|January 3, 2020
Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate CancerSulgi Park, Chung-Seog Song, Chun-Lin Lin, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
British Journal of Cancer|September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bonesPaulina Nastały, Sara Stoupiec, Marta Popęda, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Cancer|February 14, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillanceJonathan L Wright, Jeannette M Schenk, Roman Gulati, et al.
Plos One|August 13, 2013
Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxiaHeather H Cheng, Patrick S Mitchell, Evan M Kroh, et al.
The Journal of Clinical Investigation|November 25, 2010
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progressionAnkur Sharma, Wen-Shuz Yeow, Adam Ertel, et al.
Oncotarget|October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathwaysLisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.
Pageof 18